Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin

Malfertheiner, 2007, Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report, Gut, 56, 772, 10.1136/gut.2006.101634

Chey, 2007, American College of Gastroenterology guideline on the management of Helicobacter pylori infection, Am J Gastroenterol, 102, 1808, 10.1111/j.1572-0241.2007.01393.x

Gisbert, 2005, Eradication treatment of Helicobacter pylori. Recommendations of the II Spanish Consensus Conference, Med Clin (Barc), 125, 301, 10.1157/13078424

de Boer, 2000, Regular review: treatment of Helicobacter pylori infection, BMJ, 320, 31, 10.1136/bmj.320.7226.31

Axon, 2000, Treatment of Helicobacter pylori: an overview, Aliment Pharmacol Ther, 14, 1, 10.1046/j.1365-2036.2000.00394.x

Gisbert, 2002, Review article: Helicobacter pylori “rescue” regimen when proton pump inhibitor-based triple therapies fail, Aliment Pharmacol Ther, 16, 1047, 10.1046/j.1365-2036.2002.01276.x

Gisbert, 2005, Helicobacter pylori “rescue” therapy after failure of two eradication treatments, Helicobacter, 10, 363, 10.1111/j.1523-5378.2005.00324.x

Gisbert, 2005, Helicobacter pylori first-line treatment and rescue options in patients allergic to penicillin, Aliment Pharmacol Ther, 22, 1041, 10.1111/j.1365-2036.2005.02687.x

Rodriguez-Torres, 2005, High eradication rates of Helicobacter pylori infection with first- and second-line combination of esomeprazole, tetracycline, and metronidazole in patients allergic to penicillin, Dig Dis Sci, 50, 634, 10.1007/s10620-005-2549-1

Gisbert, 2004, The TETRA study: a prospective evaluation of Helicobacter pylori ‘test-and-treat’ strategy on 736 patients in clinical practice, Helicobacter, 9, 28, 10.1111/j.1083-4389.2004.00195.x

Gisbert, 2000, Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori, Aliment Pharmacol Ther, 14, 1319, 10.1046/j.1365-2036.2000.00844.x

Gisbert, 2001, Helicobacter pylori resistance to metronidazole and to clarithromycin in Spain. A systematic review, Med Clin (Barc), 116, 111, 10.1016/S0025-7753(01)71738-1

Peitz, 1999, A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy, Drugs, 57, 905, 10.2165/00003495-199957060-00006

Peitz, 2002, High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study, Aliment Pharmacol Ther, 16, 315, 10.1046/j.1365-2036.2002.01173.x

Megraud, 2004, H. pylori antibiotic resistance: prevalence, importance, and advances in testing, Gut, 53, 1374, 10.1136/gut.2003.022111

Beales, 2001, Efficacy of Helicobacter pylori eradication therapies: a single centre observational study, BMC Gastroenterol, 1, 7, 10.1186/1471-230X-1-7

Gisbert, 2005, Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication, Helicobacter, 10, 157, 10.1111/j.1523-5378.2005.00307.x

Houben, 1999, A systematic review of Helicobacter pylori eradication therapy—the impact of antimicrobial resistance on eradication rates, Aliment Pharmacol Ther, 13, 1047, 10.1046/j.1365-2036.1999.00555.x

Anderson, 2008, Levofloxacin: a review of its use as a high-dose, short-course treatment for bacterial infection, Drugs, 68, 535, 10.2165/00003495-200868040-00011

Gisbert, 2008, Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients, Am J Gastroenterol, 103, 71, 10.1111/j.1572-0241.2007.01500.x

Saad, 2006, Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis, Am J Gastroenterol, 101, 488, 10.1111/j.1572-0241.2006.00637.x

Gisbert, 2006, Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure, Aliment Pharmacol Ther, 23, 35, 10.1111/j.1365-2036.2006.02737.x

Vaira, 2007, How to proceed in Helicobacter pylori-positive chronic gastritis refractory to first- and second-line eradication therapy, Dig Dis, 25, 203, 10.1159/000103885

Sanchez, 2000, Susceptibility of Helicobacter pylori to mupirocin, oxazolidinones, quinupristin/dalfopristin and new quinolones, J Antimicrob Chemother, 46, 283, 10.1093/jac/46.2.283

Tanaka, 2002, Synergic effect of quinolone antibacterial agents and proton pump inhibitors on Helicobacter pylori, J Antimicrob Chemother, 49, 1039, 10.1093/jac/dkf055

Watanabe, 2003, Levofloxacin based triple therapy as a second-line treatment after failure of Helicobacter pylori eradication with standard triple therapy, Dig Liver Dis, 35, 711, 10.1016/S1590-8658(03)00432-8

Antos, 2006, 7-Day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity, Helicobacter, 11, 39, 10.1111/j.0083-8703.2006.00375.x

Yahav, 2006, In vitro activity of levofloxacin against Helicobacter pylori isolates from patients after treatment failure, Diagn Microbiol Infect Dis, 55, 81, 10.1016/j.diagmicrobio.2005.12.003

Bilardi, 2004, A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial, Clin Gastroenterol Hepatol, 2, 997, 10.1016/S1542-3565(04)00458-6

Gatta, 2005, A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses, Aliment Pharmacol Ther, 22, 45, 10.1111/j.1365-2036.2005.02522.x

Matsumoto, 2005, Levofloxacin- versus metronidazole-based rescue therapy for H. pylori infection in Japan, Dig Liver Dis, 37, 821, 10.1016/j.dld.2005.06.002

Cammarota, 2000, Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection, Aliment Pharmacol Ther, 14, 1339, 10.1046/j.1365-2036.2000.00846.x

Di Caro, 2002, Levofloxacin based regimens for the eradication of Helicobacter pylori, Eur J Gastroenterol Hepatol, 14, 1309, 10.1097/00042737-200212000-00004

Gisbert, 2009, Levofloxacin, amoxicillin and omeprazole as first-line triple therapy for Helicobacter pylori eradication, J Clin Gastroenterol, 43, 384, 10.1097/MCG.0b013e31816d921c

Marzio, 2006, Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole, Helicobacter, 11, 237, 10.1111/j.1523-5378.2006.00407.x

Rispo, 2007, Levofloxacin in first-line treatment of Helicobacter pylori infection, Helicobacter, 12, 364, 10.1111/j.1523-5378.2007.00517.x

Croom, 2003, Levofloxacin: a review of its use in the treatment of bacterial infections in the United States, Drugs, 63, 2769, 10.2165/00003495-200363240-00008